Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Escitalopram (Generic Health) TM
Active ingredients: escitalopram
What it is used for
Treatment of major depression.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to off-white, round, film coated tablets debossed with "10" on one side and scored on the other side which contain escitalopram (as oxalate) 10mg.
Food interactions
For the active ingredient escitalopram
- Take without regard to meals.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient escitalopram
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Selective serotonin reuptake inhibitors (SSRIs) for depression - myDr.com.au
Selective serotonin reuptake inhibitors (SSRIs) are medicines used to treatdepression and anxiety. In fact, they are the most commonly prescribed type of antidepressant medicine in Australia.&nb
Read more on myDr website
Non-hormonal treatment options for menopausal symptoms - Australasian Menopause Society
At menopause, changes in hormone levels can cause symptoms for many women for example, hot flushes, mood and sleep changes. If your symptoms are bothering you, your doctor can help you to understand your symptoms and your treatment options.
Read more on Australasian Menopause Society website
Antidepressant Medication
There is a lot of misinformation about antidepressant medication and there is no simple explanation as to how it works. Medication can be important in the treatment of moderate to severe depression and in some anxiety conditions.
Read more on beyondblue website
Top results
Second-generation antidepressants for winter depression | Cochrane
Seasonal affective disorder (winter depression) is a type of depression that recurs in the autumn and lasts until the spring. It is similar to regular depression except sufferers are usually very tired and have an increase in their appetite. It is more common in countries with few daylight hours in winter. One of the mainstays of treatment for all depression, including winter depression, are second-generation antidepressants (SGAs) such as selective serotonin reuptake inhibitors (SSRIs), and serotonin and norepinephrine reuptake inhibitors (SNRIs). It is not clear how well these drugs work for winter depression and how they compare to each other or to other types of therapy such as light therapy.
Read more on Cochrane (Australasian Centre) website
Duloxetine versus other antidepressive agents for depression | Cochrane
Although pharmacological and psychological interventions are both effective for major depression, antidepressant drugs remain the mainstay of treatment in moderate to severe major depression. During the last 20 years, newer compounds (such as selective serotonin reuptake inhibitors and dual action agents such as serotonin noradrenalin reuptake inhibitors) have progressively become the most commonly prescribed antidepressants. Duloxetine hydrochloride, one of the most recent antidepressants introduced in the market, is a selective serotonin noradrenergic reuptake inhibitor for oral administration. In the present review we assessed the evidence for the efficacy, acceptability and tolerability of duloxetine in comparison with all other antidepressants in the acute-phase treatment of major depression. Sixteen randomised controlled trials (5735 participants) were included. Duloxetine was not more effective than some other new antidepressant agents in the acute-phase treatment of major depression, and it was less well tolerated than escitalopram and venlafaxine as more patients allocated to duloxetine withdrew treatment before study end. However, due to the limited number of studies per comparison these results should be interpreted with caution.
Read more on Cochrane (Australasian Centre) website
Medications to prevent post-traumatic stress disorder (PTSD): a review of the evidence | Cochrane
PTSD is a condition experienced by some people after traumatic experiences such as warfare or domestic violence.People with PTSD experience symptoms of intense fear, helplessness and horror.Research suggests that changes in stress hormones in the brain may contribute to PTSD.Giving people medications which work in the brain soon after traumatic events may be able to prevent PTSD from developing.
Read more on Cochrane (Australasian Centre) website
Managing obsessive compulsive disorder | Issue 4 | Volume 38 | Australian Prescriber
Unlike obsessive compulsive personality traits or occasional repetitive habits, obsessive compulsive disorder can be highly distressing and associated with...
Read more on Australian Prescriber website
Switching and stopping antidepressants | Issue 3 | Volume 39 | Australian Prescriber
Switching people from one antidepressant to another is commonly needed but can cause drug withdrawal symptoms, drug interactions and relapse in depression....
Read more on Australian Prescriber website
NonHormonal Treatments for Menopausal Symptoms - Australasian Menopause Society
Many women request non-hormonal treatments for menopausal symptoms. This information sheet addresses the evidence concerning safety and efficacy of currently available non-hormonal treatments for menopausal symptoms
Read more on Australasian Menopause Society website
Risk assessment of drug-induced QT prolongation | Issue 1 | Volume 38 | Australian Prescriber
Drugs can cause prolongation of the QT interval, alone or in combination, potentially leading to fatal arrhythmias such as torsades de pointes. When...
Read more on Australian Prescriber website
Functional dyspepsia | Australian Prescriber
Distinguishing between functional dyspepsia and reflux disease can be challenging find out what to look out for and how to tailor treatment.
Read more on Australian Prescriber website
